LI-COR Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:LI-COR Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014084
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnology, plant biology, drug discovery and environmental research. LCB’s products include genomics reagents, western blot reagents, protease assay reagents, other optical imaging reagents, pearl cam software and protein gel combs. The company’s products find application in gas analysis, eddy covariance, photosynthesis, soil gas flux, light measurement, and others. It distributes its products through distributions centers in Africa, Asia, Europe, and North and Central America. LCB is headquartered in Lincoln, Nebraska, the US.

LI-COR Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LI-COR Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LI-COR Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LI-COR Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LI-COR Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
LI-COR Inc, Medical Devices Deals, 2011 to YTD 2017 9
LI-COR Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
LI-COR Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aura Biosciences Raises USD21 Million in Series B Financing 11
Licensing Agreements 12
TriLink BioTechnologies Enters Into Licensing Agreement With Li-cor Biosciences 12
Cambridge Research Biochemicals Enters Into Licensing Agreement With Li-Cor Biosciences For Infrared Dye-Labeled Peptides 13
LI-COR Inc – Key Competitors 14
LI-COR Inc – Key Employees 15
LI-COR Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Product News 17
Mar 29, 2017: LI-COR Sponsors Clinical Trial For Near Infrared Surgical Imaging 17
Other Significant Developments 18
Aug 30, 2016: LI-COR Now Offers Contract Manufacturing for Early-Phase cGMP Materials 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
LI-COR Inc, Pharmaceuticals & Healthcare, Key Facts 2
LI-COR Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LI-COR Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LI-COR Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LI-COR Inc, Deals By Therapy Area, 2011 to YTD 2017 8
LI-COR Inc, Medical Devices Deals, 2011 to YTD 2017 9
LI-COR Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aura Biosciences Raises USD21 Million in Series B Financing 11
TriLink BioTechnologies Enters Into Licensing Agreement With Li-cor Biosciences 12
Cambridge Research Biochemicals Enters Into Licensing Agreement With Li-Cor Biosciences For Infrared Dye-Labeled Peptides 13
LI-COR Inc, Key Competitors 14
LI-COR Inc, Key Employees 15
LI-COR Inc, Subsidiaries 16

★海外企業調査レポート[LI-COR Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • San Leon Energy Plc (SLE):企業の財務・戦略的SWOT分析
    Summary San Leon Energy Plc (San Leon) is an oil and gas exploration and production company. It is engaged in acquiring, exploring and developing conventional and shale oil and gas assets across Europe and North Africa. The company holds interests in Durresi Block located in offshore Albania and inc …
  • Celesio AG:企業のM&A・事業提携・投資動向
    Celesio AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celesio AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • M. A. Mortenson Company:企業の戦略・SWOT・財務情報
    M. A. Mortenson Company - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Linde AG (LIN):企業の財務・戦略的SWOT分析
    Linde AG (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Medical Transcription Billing Corp (MTBC)-医療機器分野:企業M&A・提携分析
    Summary Medical Transcription Billing Corp (Medical Transcription) is a healthcare IT company that offers web-based solutions and related business services. The company offers electronic health records, practice management software, and patient engagement software. Its products comprise ChartsPro, P …
  • Liberty Mutual Group Inc:企業のM&A・事業提携・投資動向
    Liberty Mutual Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Liberty Mutual Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Lupin Ltd (LUPIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lupin Ltd (Lupin) focuses on the development and manufacture of generic and branded formulations, biotechnology products and active pharmaceutical ingredients (APIs). The company has expertise in the areas of cardiovascular, asthma, diabetology, pediatrics, central nervous system, gastro-int …
  • Bangkok Insurance Pcl
    Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report Summary Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • XState Resources Ltd (XST):企業の財務・戦略的SWOT分析
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …
  • Cogent Communications Holdings inc (CCOI):企業の財務・戦略的SWOT分析
    Cogent Communications Holdings inc (CCOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Reliance Capital Ltd:企業の戦略・SWOT・財務情報
    Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Wabash Valley Power Association, Inc.:企業の戦略的SWOT分析
    Wabash Valley Power Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Public Financial Holdings Ltd (626)
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Telekom Slovenije, d.d. (TLSG):企業の財務・戦略的SWOT分析
    Telekom Slovenije, d.d. (TLSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Alstom SA (ALO):電力:M&Aディール及び事業提携情報
    Summary Alstom SA (Alstom) is a marketer and developer of transport systems. The company offers a wide range of solutions ranging from high-speed trains to metros and tramways including customized services such as maintenance and modernization, and infrastructure up to signaling solutions. It design …
  • Attijari Bank SA:企業の戦略・SWOT・財務分析
    Attijari Bank SA - Strategy, SWOT and Corporate Finance Report Summary Attijari Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Novartis AG:企業のM&A・事業提携・投資動向
    Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆